Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Michel Chonchol to Kaplan-Meier Estimate

This is a "connection" page, showing publications Michel Chonchol has written about Kaplan-Meier Estimate.

 
Connection Strength
 
 
 
0.368
 
  1. Tang J, Mettler P, McFann K, Chonchol M. The association of prevalent kidney stone disease with mortality in US adults: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Nephrol. 2013; 37(5):501-6.
    View in: PubMed
    Score: 0.090
  2. Nowak KL, Chonchol M, You Z, Gupta M, Gitomer B. Affected parent sex and severity of autosomal dominant polycystic kidney disease: a retrospective cohort study?. Clin Nephrol. 2018 Mar; 89(3):196-204.
    View in: PubMed
    Score: 0.032
  3. Nowak KL, Cadnapaphornchai MA, Chonchol MB, Schrier RW, Gitomer B. Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease. Am J Nephrol. 2016; 44(3):171-8.
    View in: PubMed
    Score: 0.028
  4. Deo R, Katz R, de Boer IH, Sotoodehnia N, Kestenbaum B, Mukamal KJ, Chonchol M, Sarnak MJ, Siscovick D, Shlipak MG, Ix JH. Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study. Am J Kidney Dis. 2015 Jul; 66(1):40-6.
    View in: PubMed
    Score: 0.025
  5. Mehta T, Bu?kov? P, Sarnak MJ, Chonchol M, Cauley JA, Wallace E, Fink HA, Robbins J, Jalal D. Serum urate levels and the risk of hip fractures: data from the Cardiovascular Health Study. Metabolism. 2015 Mar; 64(3):438-46.
    View in: PubMed
    Score: 0.025
  6. Jalal D, Chonchol M, Etgen T, Sander D. C-reactive protein as a predictor of cardiovascular events in elderly patients with chronic kidney disease. J Nephrol. 2012 Sep-Oct; 25(5):719-25.
    View in: PubMed
    Score: 0.022
  7. Targher G, Zoppini G, Mantovani W, Chonchol M, Negri C, Stoico V, Mantovani A, De Santi F, Bonora E. Comparison of two creatinine-based estimating equations in predicting all-cause and cardiovascular mortality in patients with type 2 diabetes. Diabetes Care. 2012 Nov; 35(11):2347-53.
    View in: PubMed
    Score: 0.021
  8. van Kuijk JP, Flu WJ, Valentijn TM, Chonchol M, Vo?te MT, Kuiper RJ, Verhagen HJ, Bax JJ, Poldermans D. Preoperative left ventricular dysfunction predisposes to postoperative acute kidney injury and long-term mortality. J Nephrol. 2011 Nov-Dec; 24(6):764-70.
    View in: PubMed
    Score: 0.020
  9. van Kuijk JP, Flu WJ, Galal W, Chonchol M, Goei D, Verhagen HJ, Bax JJ, Poldermans D. The influence of polyvascular disease on the obesity paradox in vascular surgery patients. J Vasc Surg. 2011 Feb; 53(2):399-406.
    View in: PubMed
    Score: 0.019
  10. Winkel TA, Schouten O, Hoeks SE, Vo?te MT, Chonchol M, Goei D, Flu WJ, van Kuijk JP, Lindemans J, Verhagen HJ, Bax JJ, Poldermans D. Prognosis of vascular surgery patients using a quantitative assessment of troponin T release: is the crystal ball still clear? Eur J Vasc Endovasc Surg. 2010 Dec; 40(6):739-46.
    View in: PubMed
    Score: 0.019
  11. van Kuijk JP, Flu WJ, Chonchol M, Welten GM, Verhagen HJ, Bax JJ, Poldermans D. The prevalence and prognostic implications of polyvascular atherosclerotic disease in patients with chronic kidney disease. Nephrol Dial Transplant. 2010 Jun; 25(6):1882-8.
    View in: PubMed
    Score: 0.018
  12. van Kuijk JP, Flu WJ, Welten GM, Hoeks SE, Chonchol M, Vidakovic R, Verhagen HJ, Bax JJ, Poldermans D. Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease. Eur Heart J. 2010 Apr; 31(8):992-9.
    View in: PubMed
    Score: 0.018
  13. Welten GM, Chonchol M, Hoeks SE, Schouten O, Bax JJ, Dunkelgr?n M, van Gestel YR, Feringa HH, van Domburg RT, Poldermans D. Beta-blockers improve outcomes in kidney disease patients having noncardiac vascular surgery. Kidney Int. 2007 Dec; 72(12):1527-34.
    View in: PubMed
    Score: 0.015
  14. Feringa HH, Karagiannis SE, Chonchol M, Vidakovic R, Noordzij PG, Elhendy A, van Domburg RT, Welten G, Schouten O, Bax JJ, Berl T, Poldermans D. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors. J Am Soc Nephrol. 2007 Jun; 18(6):1872-9.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)